Department of Medicine - Bone Metabolism
Home  >  Departments  >  Medicine  >  Divisions  >  Endocrinology  >  Bone Metabolism  >  

Meet J.C. Gallagher, M.D.

  J. Christopher Gallagher M.D.
  Professor of Medicine
  Director, Bone Metabolism Unit
  Division of Endocrinology

  Contact Information

  Creighton Endocrinology -- CUMC
  601 North 30th Street, Suite 6712
  Omaha, NE 68131                         
  Phone: 402.280.4516
  Fax:  402.280.4517
  E-mail :


Dr. Gallagher is a Professor of Medicine and endocrinologist for Creighton University. He graduated from medical school in England in 1964, completed his Residency in the UK and completed his Endocrine Fellowship at Mayo Clinic. Dr. Gallagher been with Creighton University for many years and is the author of many publications on Osteoporosis, Vitamin D, and Hormone Replacement Therapy.

PUBLICATIONS - Dr. J.C. Gallagher

1.          Bullamore JR., Gallagher JC., Wilkinson R and Nordin  BEC.  Effect of Age on Calcium Absorption. Lancet 11:535-537, 1970.

2.          Gallagher JC, Young MM and Nordin BEC.  Effect of artificial menopause on plasma and urine calcium and phosphate.  Clinical Endocrinology, 1:57-64, 1972.

3.          Gallagher JC. and Nordin BEC.  Treatment with Oestrogens of Primary Hyperparathyroidism in postmenopausal women.  Lancet i:503-507, 1972.

4.          Nordin BEC, Aaron J, Gallagher JC. and Horsman A.  Calcium and bone metabolism in old age. In:  Nutrition in Old Age.  Ed. LA Carison, Uppsala, Sweden, 1972, pp. 77-85.

5.          Gallagher JC, Aaron J, Nicholson M, Longton E, and Nordin BEC.  The rule of osteoporosis and osteomalacia in fractures of the femoral neck.  J Bone and Joint Surgery, 54B:192, 1972.

6.          Gallagher JC and Nordin BEC.  Oestrogens and Calcium Metabolism.  In:  Aging and Estrogens. Frontiers of Hormone Research, 2:Karger, Basel, 1973, pp. 98-117

7.          Gallagher JC, Aaron J, Horsman A, Marshall DH, Wilkinson R, Nordin BEC.  The crush fracture syndrome in postmenopausal women.  Clinics in Endocrinology and Metabolism.  2:293-315, 1973.

8.          Gallagher JC, Aaron J, Horsman A, Wilkinson R and Nordin BEC.  Corticosteroid Osteoporosis. Clinics in Endocrinology and Metabolism, 2:355-368, 1973.

9.          Gallagher JC, Bulusu L, Nordin BEC.  Oestrogenic hormones and bone resorption.  In:  Clinical Aspects of Metabolic Bone Disease.  Eds.  Frame B, Parfitt AM, Duncan H, International Congress Series No. 270, Excerpta Medica, Amsterdam, 1973, pp. 266-273.

10.      Gallagher JC, Nordin BEC.  Hormones and calcium metabolism Organorama 10:3-10, 1973.

11.      Cochran M, Cook MG, Gallagher JC, Peacock M.  Hypogammglobulinaemia with Whipple's disease.  Postgraduate Medical Journal, 49:355-358, 1973.

12.      Gallagher JC, Wilkinson R.  The effect of ethinyloestradiol on calcium and phosphorus metabolism of postmenopausal women with primary hyperparathyroidism.  Clinical Science and Molecular Medicine, 45:785-802, 1973.

13.      Aaron J, Gallagher JC, Anderson J, Longton EB, Nordin BEC.  The incidence of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet i:February 16, 1974.

14.      Gallagher JC, Nordin BEC.  Hormones and calcium metabolism.  In:  Biochemistry of Women: Clinical Concepts.  Currey AS , JV Hewitt, Eds. CRC Press, Ohio, 1974, pp. 145-163.

15.      Gallagher JC, Horsman A, Nordin BEC.  Osteoporosis and the menopause.  In:  Menopausal Syndromes.  Greenblatt, Mahesh, McDonagh, Eds.  Medcom, New York, 1974, pp. 38-48.

16.      Gallagher JC, Nordin BEC.  Hormones and the menopause.  (Paris) Actualite Genecologiques 4 serie, 1974.

17.      Peacock M, Gallagher, JC, Nordin BEC.  Effect of 1,alpha hydroxy D3 on calcium absorption and bone resorption.  Lancet i:February 25, 1974.

18.      Nordin BEC, Horsman A, Gallagher JC.  The effect of vitamin D on bone loss in spinal osteoporosis.  In:  Symposium on Bone Mineral Determination (Sweden) 1974.

19.      Aaron J, Gallagher JC, Nordin BEC.  Seasonal variations of histological osteomalacia in femoral neck fracture.  Lancet ii:84, 1974.

20.      Robertson WG, Gallagher JC, Marshall DH, Peacock M, Nordin BEC.  Seasonal variations in the urinary excretion of calcium.  British Medical Journal, November 23, 1974.

21.      Nordin BEC, Horsman A, Gallagher JC.  Effect of various therapies on bone loss in women.  In: Calcium Metabolism, Bone and Metabolic Bone Disease. Eds.  Kuhlencordt F, Kruse H.P.  Publishers, Springer-Verlag, New York, 1975, pp. 233-242.

22.      Gallagher JC, Nordin BEC.  Effects of oestrogen and progestogen therapy on calcium metabolism in postmenopausal women.  In:  Estrogens in the Postmenopause.  Frontiers of Hormone Research, 3, 1975, pp. 15-176.

23.      Nordin BEC, Gallagher JC, Aaron JE, Horsman A.  Postmenopausal osteopenia and osteoporosis.  In:  Estrogens in the Postmenopause.  Frontiers of Hormone Research, 3, 1975, pp. 131-149.

24.      Davies T, McNicol GP, Fieldhouse G, Gallagher JC, Nordin BEC.  A comparison of the effects of oestriol succinate and ethinyoestradiol on blood coagulation, platelet function and fibrinolysis in postmenopausal women.  In:  Estrogens in the postmenopause.  Frontiers of Hormone Research, 3, 1975, pp. 185-198.

25.      Peacock M, Nordin BEC, Gallagher JC, Varnivides C.  Action of 1,alpha hydroxyvitamin D3 in man.  2nd Workshop on vitamin D.  Vitamin D and problems Related to Uremic Bone Disease. Eds. Norman AW, Schaefer K, Grigoleit HG, Herrath DV, Ritz E, 1975.

26.      Nordin BEC, Horsman A, Aaron J, Gallagher JC.  Postmenopausal Bone Loss.  Current Medical Research and Opinion, Vol. 3, Supple, 3, pp. 28-38, 1975.

27.      Nordin BEC, Wilkinson R, Marshall DH, Gallagher JC, Williams A, Peacock M.  Calcium Absorption in the Elderly.  XI Symposium on Calcified Tissues - (Copenhagen), 1975.  Calcified Tissue Research, Vol. 218:442-451, 1976.

28.      Horsman A, Nordin BEC, Gallagher JC, Kirby PA, Milner RM, Simpson M.  Observations of sequential changes in bone mass in postmenopausal women: A controlled trial of oestrogen and calcium therapy.  XII European Symposium on Calcified Tissues - (York), 1976.  Calcified Tissue Research, Vol 22S:78-84, 1977.

29.      Marshall DH, Gallagher JC, Guha P, Hanes F, Oldfield W, Nordin BEC.  Effect of 1,alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of postmenopausal osteoporosis.  XII European Symposium on Calcified Tissue Research, Vol. 22S:78-84, 1977.

30.      Riggs BL, Gallagher JC.  Evidence for bihormonal deficiency stage (estrogen and 1,25-dihydroxyvitamin D) in-patients with postmenopausal osteoporosis.  3rd Workshop on Vitamin D (Asilomar, 1977) in: Vitamin D.  Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism.  Eds. Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Herrath DV, 1977.

31.      Horsman A, Gallagher JC, Simpson M, Nordin BEC:  Prospective trial of oestrogen and calcium in postmenopausal women.  Brit. Med Journal, 2:789-792, 1977.

32.      Klein RC, Arnaud SB, Gallagher JC, DeLuca H, Riggs BL.  Intestinal calcium absorption in exogenous hypercortisonism.  J Clin Invest, 60:253-259, 1977.

33.      Nordin BEC, Marshall DH, Horsman A, Gallagher JC.  Oestrogens and calcium metabolism. Sandoz.  Ed. D. Hioco, 1976. 

34.      Nordin BEC, Aaron JW, Gallagher JC, Horsman A, Marshall DH.  Are fractures in the elderly preventable?  Modern geriatrics, 4:11-18, 1977.

35.      Riggs BL, Gallagher JC.  Intestinal calcium absorption in postmenopausal osteoporosis: possible role of vitamin D.  Proceedings of the 6th International Symposium on Parathyroid Hormone (Vancouver, 1977).

36.      Gallagher JC. and Riggs BL.  Nutrition and bone disease.  New England Journal of Medicine 298:193-195, 1978.

37.      Gallagher JC, Riggs BL, DeLuca, HF.  Effect of treatment with synthetic 1,25 (OH)2D in postmenopausal osteoporosis.  Berlin, 1979. 

38.      Riggs BL, Gallagher JC, DeLuca HF.  Serum vitamin D metabolites and intestinal calcium absorption in normal, elderly and osteoporotic subjects.  Vitamin D.  Basic research and its clinical application. Eds. Norman AW, et. al.  de Gruyter W, Berlin, 1979. p. 107-113.

39.      Riggs BL, Gallagher JC, DeLuca HF, Edis AJ, Lambert PW, Arnaud CD:  A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone and inappropriately low serum 1,25 dihydroxyvitamin D.  Mayo Clinic Proc.  53:701-706, 1978.

40.      Gallagher JC, Riggs BL, Arnaud CD.  The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women.  J Lab Clin Med  85:373-385, 1980.

41.      Gallagher JC, Riggs BL, Eisman J, Hamston A, Arnaud SB, DeLuca HF.  Intestinal calcium absorption and serum vitamin D metabolites in normal and osteoporotic patients.  Effect of age and dietary calcium.  J Clin Invest 64:729-736, 1979.

42.      Gallagher JC, Melton LJ, Riggs BL, Bergstrath E.  Epidemiology of fractures of Proximal Femur in Rochester, Minnesota, USA Clin Orthopaed, & Rel Res 150:163-171, 1980.

43.      Owen RA, Melton LJ, Gallagher JC, Riggs BL.  The National cost of Acute Care for Hip Fractures due to Osteoporosis.  Clin Orthopaed & Rel Res 150:172-176, 1980.

44.      Gallagher JC, Melton LJ, Riggs BL.  Examination of Prevalence Rate of possible risk factors in a population with fracture of proximal femur.  Clin Orthop & Rel Res 153:158-165, 1980.

45.      Gallagher JC, Riggs BL, DeLuca HF.  Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.  J Clin Endocr Metab 51:1359-1364, 1980.

46.      Gallagher JC, Riggs BL, DeLuca HF.  Effects of Calcitriol in Osteoporosis, in Recent Advances in Osteoporosis. Ed. DeLuca HF, Parfitt AM, Jee W, Johnston C. University Park Press, Baltimore, 215-224, 1981.

47.      Gallagher JC.  Biochemical Effects of Estrogen and Progesterone on Calcium Metabolism, in Recent Advances in Osteoporosis. Ed.  DeLuca HF, Parfitt AM, Jee W, Johnston C.  University Park Press, Baltimore, 215-224, 1981.

48.      Arnaud CD, Gallagher JC, Jerpbak CM, Riggs BL.  On the Role of Parathyroid Hormone in the Osteoporosis of Aging. In: Osteoporosis: Recent Advances in Pathogenesis and Treatment, Eds.  DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM.  University Park Press, Baltimore, 1981, 215-224.

49.      Riggs BL, Gallagher JC, DeLuca HF.  Disordered Systemic Regulation of Mineral homeostasis as a Cause of Osteoporosis.  In:  Osteoporosis Recent Advances in Pathogenesis and Treatment, Eds.  DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM.  University Park Press, Baltimore, 1981, 353-358.

50.      Gallagher JC.  The Absorption of Calcium in Health and Disease.  In: Calcium in Normal and Pathological Biological Systems, Ed.  Anghileri L.  CRC Press, Cleveland, 1982.

51.     Riggs BL, Gallagher JC, DeLuca HF, Zinsmeister AR.  Studies on the Mechanism of Impaired Calcium Absorption in Postmenopausal Osteoporosis.  In:  Vitamin D Clinical, Biochemical and Clinical Endocrinology of Calcium Metabolism.  Eds.  Norman A et al, W. de Gruyter, Berlin, 1982, p. 903-908.

52.      Gallagher JC, Jerpbak CM, Jee WSS, Johnston KA, DeLuca HF, Riggs BL.  Administration of 1,25-Dihydroxyvitamin D3 to patients with Postmenopausal Osteoporosis:  Short- and long-term Effects on Bone and Calcium Metabolism.  Proc Nat Acad. Sci 79, 3325-3329, 1982.

53.      Gallagher JC.  The Use of 1,25-Dihydroxyvitamin D3 in Osteoporosis. In:  Vitamin D Clinical, Biochemical and Clinical Endocrinology of Calcium Metabolism.  Eds.  Norman A et al, De Gruyter W, Berlin, 1982, p. 903-908.

54.      Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD.  Calcium Nutrition and bone health in the elderly.  Am J Clin Nutr 36, 986-1013, 1982.

55.      Parfitt AM, Gallagher JC, Neer R, Heaney RP, Johnston CC, Whedon GD.  Vitamin D and bone health in the elderly.  Am J Clin Nutr 36, 1014-1031, 1982.

56.      Milhaud G, Christiansen C, Gallagher JC, Reeve J, Seeman E, Chestnut C and Parfitt AM.  Pathogenesis and Treatment of Postmenopausal Osteoporosis.  Calcif Tissue Int 35:708-711 (1983).

57.      Gallagher JC.  The Use of Calcitriol (1,25 Dihydroxyvitamin D).  In: Osteoporosis, in Clinical Disorders of Bone and Mineral Metabolism.  Eds. Boy Frame and J Potts.  Excerpta Medica S617, 1983.

58.      Gallagher JC.  The Role of Vitamin D in the Treatment of Postmenopausal Osteoporosis.  In Calcium Disorders of Bone.  Eds.  Christiansen C et. al. Copenhagen, 1984.

59.      Gallagher JC.  Osteoporosis and Fractures.  Ayerst Labs, 1984.

60.      Gallagher JC.  Clinical Simulations in Obstetrics and Gynecology:  Osteoporosis Medical Age Publ. Co. Connecticut, 1984.

61.      Gallagher JC, Goldgar D, Mahoney P, McGill J.  Measurement of Spine Density in Normal and Osteoporotic Subjects Using Computerized Tomography.  Relationship of Spine Density to Fracture Threshold and Fracture Index.  J Comput Assit Tomogr 9(3): 634-635, 1985.

62.      Gallagher JC.  Method of Osteoporosis.  In: Conn's Current Therapy.  Ed.  Rakel RR, Saunders.  1985.

63.      Mack LA, Hanson JA, Kilcoyne RF, Ott SM, Gallagher JC, Chestnut CH.  Correlation between fracture index and bone densitometry by CT and dual photon absorptiometry in J Comput Assist Tomogr, 9(3):635-636, 1985.

64.      Gallagher JC.  Prevention of Osteoporosis.  Int. Corr Sec Obst, Gyn, 27, 6, 1986.

65.      Gallagher JC, Recker R.  A Comparison between High Dose Calcitriol and Calcium Supplements in Osteoporosis.  Vitamin D, Chemical, Biochemical and Clinical Update.  Ed. Norman AW, Schaefer K, Grigoleit HG, v. Herrath D, de Gruyter W, Berlin.  1985.

66.      Pak CYC, Sakhaee K, Gallagher JC, Parcel C.  Attainment of Therapeutic Fluoride Levels in Serum without Major Side Effects Using a Slow-Release Preparation of Sodium Fluoride in Postmenopausal Osteoporosis.  J Bone Min Res, 1:563-571, 1986.

67.      Gallagher JC.  Estrogens and Alternative Therapies for Osteoporosis.  Int Corr Soc Obst Gynecol, 27, 3, 1986.

68.      Eisman J, Gallagher JC.  Recent advances in the management of osteoporosis.  Symposium Sydney Australia. Excerpta Medica, Amsterdam, New York, 1986.

69.      Kable WT, Gallagher JC.  What is the Proper Treatment of Adenomatous Hyperplasia Without Atypia?  Int. Corresp. Soc Obst Gynecol, 28, 8, 1987.

70.      Gallagher JC.  Treatment of Osteoporosis With Vitamin D Analogues.  In:  Osteoporosis:  p 70-72 Current Concepts Report of the Seventh Ross Conference on Medical Research.  Ross Laboratories, Columbus, Ohio, 1987.

71.      Hedlund LR, Gallagher JC.  The Effect of Fluoride in Osteoporosis.  The Physician and Sportsmedicine, 1987, 15(11) 111-120.

72.      Gallagher JC, Goldgar D, Moy A.  Total Bone Calcium in Normal Women:  Effect of Age and Menopause Status.  J Bone Min Res, 1987 2, 6, pp. 491-496.

73.      Gallagher JC.  Vitamin D Metabolism in Osteoporosis. In Colloquia on Aging.  p 17-18, Ed.  Cannigia A et al., Instituto Scientifica Roussel Italia, Milano, Italy, No. 2, 1987.

74.      Gallagher JC.  Drug Therapy of Osteoporosis: Calcium, Estrogen and Vitamin D.  In:  Osteoporosis:  Etiology, Diagnosis, and Management.  p. 389-402 Eds.  Riggs B L, Melton III LJ.  Raven Press, New York, 1988. 

75.      Bewtra C, Kable WT, Gallagher JC.  The Endometrial Histology & Bleeding Patterns in Menopausal Women Treated with Estrogen and Different Doses of Progestin  J Reprod Med, 33(2) 205-209, 1988.

76.      Hedlund LR, Gallagher JC.  Estrogen Therapy for Postmenopausal Osteoporosis:  Current Status.  Geriatric Medicine, 7(2), 55-63, 1988. 

77.      Kable WT, Gallagher JC.  The role of Progesterone in the treatment of PMS.  Internat Corr Soc Obst Gyn 2a(6), 5, 1988.

78.      Gallagher JC.  Estrogen Replacement Update.  J Clin Practice in Sex. 14(5), 1988.

79.      Gallagher JC, Hedlund R, Stoner S, Meeger C.  Vertebral Morphometry:  Normative Data.  Bone & Mineral, 4(2) 189-196, 1988.

80.      Hedlund LR, Gallagher JC.  Vertebral Morphometry in Diagnosis of Spinal Fractures.  Bone & Mineral. 5, 59-67, 1988.

81.      Gallagher JC.  Prevention of Bone Loss by 1,25 dihydroxyvitamin D3 in Osteoporosis.  In:  Vitamin D. Chemical, Biochemical and Clinical Update.  Ed. AW Norman et al.  DeGruyter Berlin, 1988, p 750-752.

82.      Gallagher JC.  Reducing the risks of osteoporosis caused fractures.  Human Sexuality, 1988;24.

83.      Gallagher JC.  Changes in Mineral Metabolism with Immobilization/Spaceflight.  Workshop on Exercise Considerations for Space Flight.  July 1989 (NASA) Houston, Texas. 

84.      Hedlund LR, Gallagher JC.  Change in Vertebral Shape in Spinal Osteoporosis. Calcif Tiss Int 44:168-172, 1989.

85.      Hedlund LR, Gallagher JC.  Increased incidence of hip fracture in osteoporotic women treated with Sodium Fluoride. J Bone & Min Res 4(2), 223-225, 1989.

86.      Gallagher JC.  Use of Vitamin D Metabolites in Osteoporosis. Clinical Disorder of Bone and Mineral Metabolism, Eds. Kleevekoper M, Krane SM.  Liebert, New York, p. 205-209, 1989.

87.      Gallagher JC, Riggs BL, Recker R, Goldgar D.  The effect of Calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency.  Proc Soc Exp Biol Med 191, (3) p 287-292, 1989.

88.      Hedlund LF, Gallagher JC.  The Effect of Age and Menopause on Bone Mineral Density of the Proximal Femur.  J Bone & Min Res, (4) 4. p 639-642, 1989.

89.      Gallagher JC.  Treatment of osteoporosis with various therapies.  Advances in Endocrinology Vol 6 1989.  ed. T. Fujita  VIth Fuji Hormone Conference.

90.      Mazess RB, Gallagher JC, Notelovitz M, Schiff I, Utian W.  Monitoring skeletal response to estrogen.  Am J Obstet Gyn  1989;151:4:843-848. 

91.      Genant HK, Baylink DJ, Gallagher JC.  Estrogens in the prevention of osteoporosis in postmenopausal women.  Am J Obstet Gynecol 1989;161:1842-6.

92.      Gallagher JC.  The basis for 1,25 dihydroxyvitamin D therapy in the treatment of osteoporosis.  In:  Osteoporosis:  Physiological Basis, Assessment, and Treatment.  Editors HF DeLuca and R Mazess, 1990;195-199.

93.      Gallagher JC, Riggs BL.  Action of 1,25-Dihydroxy vitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate.  Metab 1990; 39: 4: Sl: 30-34. 

94.      Gallagher JC.  Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. Metab 1990;39:4:S1:27-29.

95.      Gallagher JC.  Management of persistent perimenopausal bleeding.  Int. Corr Soc Obstet Gynec 1990;31:4.

96.      Kable WT, Gallagher JC, Nachtigall L, Goldgar D.  Lipid changes after hormonal replacement therapy for the menopause.  J Reprod Med 1990;35:5:512-18. 

97.      Weinstein L, Bewtra C, Gallagher JC.  Evaluation of a continuous combined low dose regimen of estrogen-progestin for treatment of the menopausal patient.  Am J Obst & Gyn.  1990; 162:6:1534-39.

98.      Gallagher JC.  The pathogenesis of osteoporosis.  Bone and Min 1990;9:3:215-227.

99.      Gallagher JC.  Hormone replacement therapy in the prevention of osteoporosis.  Postgrad Med J 1990;15-20.

100.   Genant HK, Baylink DJ, Gallagher JC, Harris ST, Steiger P, Herber M.  Effect of estrone sulfate on post- menopausal bone loss.  Obst & Gyn 1990;76:579-584.

101.   Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF.  A comparison of iliac bone histomorphometric data in postmenopausal osteoporotic and normal subjects.  Bone & Min. 1990;11:2:217-36.

102.   Gallagher JC, Goldgar D.  Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol.  A randomized controlled study.  Ann Intern Med 1990;113:649-655.

103.   Gallagher JC, Kable WT.  Effect of progestin therapy on cortical and trabecular bone:  Comparison with estrogen.  Am J Med 1991;90:171-178.

104.   Molczyk L, Thigpen LK, Eickhoff JE, Goldgar D, Gallagher JC.  Reliability of testing on knee extensors and flexors in healthy adult women using a cybex II isokinetic dynamometer.  J Orthop Sports Phy Ther 1991;14:37-41.

105.   Hopp R, Degan J, Gallagher JC, Cassidy JT.  Estimation of bone mineral density in children with juvenile rheumatoid arthritis.  J Rheumatol 1991; 18:1235-9.

106.   Harris ST, Genant HK, Baylink DJ, Gallagher JC, Katz-Karp S, McConnell MA, Green EM, Stoll RW.  The effects of estrone sulfate (Ogen) on spinal bone density of post-menopausal women.  Arch Intern Med 1991;151:1980-1984.

107.   Gallagher JC, Kable WT.  Is ERT contraindicated in vascular disease?  International Correspondence Society of Obstetricians & Gynecologists, 1991; 151:1980-1984.

108.   Gallagher JC.  Long term treatment in osteoporosis with 1,25 dihydroxyvitamin D therapy.  In:  Vitamin D:  Gene Regulation, Structure-Function Analysis, and Clinical Application.  Proceedings of the Eighth Workshop on Vitamin D, Paris, France, 1991.  Editors AW Norman, R Bouilon, and M Thomasset.

109.   Gallagher JC.  Pathophysiology of Osteoporosis.  Seminar Nephrology 1992; 12:2:109-115.

110.   Gallagher JC.  Risks/Benefits of Hormone Replacement Therapy.  Cardiovascular Health and Disease in Women.  Proceedings of a National Heart, Lung, and Blood Institute Conference.  Eds. Wenger NK, L Speroff, Packard B.  LeJacq Communications, Connecticut USA 1992.

111.   Gallagher JC.  Vitamin D Metabolism and Therapy in Elderly Subjects.  South Med J 1992;85:S2:43-47.

112.   Greep N, Anderson AL, Gallagher JC.  Thallassemia minor:  a risk factor for osteoporosis?  Bone & Mineral, 1992; 16:63-72.

113.   Gallagher JC.  Prevention of bone loss in post-menopausal and senile osteoporosis with vitamin D analogues.  Osteo Int, 1993; 3(1):172-175.

114.   Eickhoff J, Molczyk L, Gallagher JC.  Influence of isotonic, isometric and isokinetic muscle strength on bone mineral density of the spine and femur in young women.  Bone & Mineral (in press 1992).

115.   Gallagher JC.  Treatment of osteoporosis with vitamin D, vitamin D metabolites or vitamin D analogues.  In:  Fourth International Symposium on Osteoporosis and Consensus Development Conference.  Eds. C. Christiansen and B. Riis, 1993, 538-540.

116.   Gallagher JC.  Pathogenesis of postmenopausal osteoporosis:  The role of calcitriol therapy.  In:  Fourth  International Symposium on Osteoporosis and Consensus Development Conference.  Eds. C. Christiansen and B. Riis, 1993, 538-540.

117.   Gallagher JC, Fillion A.  Calcium and vitamin D.  In: Comprehensive Management of Menopause.  Eds. Lorrain et al.  Springer-Verlag, New York, 1993, 137-158.

118.   Gallagher JC.  Effect of gonadotropin-releasing hormone agonists on bone metabolism.  Sem Rep Endocrin, 1993;11(2):201-207.

119.   Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF.  Effects of increasing doses of 1-alpha hydroxyvitamin D2 (1a-OH-D2) on calcium homeostasis in postmenopausal osteopenic women.  J. Bone & Min Res, 1993;9(5):607-619.

120.   Gallagher JC.  Antiresorptive therapy in osteoporosis.  In:  Spine.  State of the Art Reviews - Vertebral Osteoporosis.  Eds. C. Cooper and J. Reeve.  1994, 199-224.

121.   Kinberg K, Hopp R, Biven R, Gallagher JC.  Bone mineral density in normal and asthmatic children.  J Allergy Clin Immunol, 94:490-7, 1994.

122.   Gallagher JC.  Vitamin D metabolism and therapy of osteoporosis.  Aktuelle Rheumatologie, S1(19):1-36, 1994.

123.   Gallagher JC.  Long term treatment of postmenopausal osteoporosis with 1,25-dihydroxyvitamin D3.  In:  Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications.  Eds. AW Norman, R Bouillon M Thomasset.  Walter de Gruyter, Berlin, 1994.

124.   Kable WT, Gallagher JC.  Response.  Collected Letters.  Int Corr Soc Obst Gyn 35(3):7-8, March 1994

125.   Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH.  Which patients will benefit from HRT?  Patient Care, Supplement;3-9, December 15, 1994

126.   Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH.  Tailoring the regimen to the patient.  Patient Care, Supplement;11-15, December 15, 1994

127.   Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH.  Compliance:  Smoothing the way.  Patient Care, Supplement;16-21, December 15, 1994

128.   Bush TL, Dawood MY, Gallagher JC, Hulka BS, Lindsay R, Utian WH.  Update:  The benefits and risks of HRT.  Patient Care, Supplement;23-29, December 15, 1994

129.   Hopp RJ, Degan JA, Phelan J, Lappe J, Gallagher JC.  Cross-sectional study of bone density in asthmatic children.  Pediatric Pulm 1995;20:189-192

130.   Hopp RJ, Degan JA, Bien RE, Kinberg K, Gallagher JC.  Longitudinal assessment of bone mineral density in children with chronic asthma.  Ann Allergy, Asthma & Immunol 1995,75:143-148

131.   Laya M, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L.  Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.  RSNA 1995:433-437

132.   Gallagher JC, Ravnikar V, Hulka BS, Villablanca AC.  HRT:  Where do we stand today?  Patient Care Supplement 1995 December pp 9-16  

133.   Gallagher JC.  Treatment of osteoporosis with calcium and vitamin D.  In:  Osteoporosis.  Eds. BL Riggs and LJ Melton, Lippincott-Raven, New York.  1996:371-390

134.   Gallagher JC.  Estrogen:  Prevention and Treatment of Osteoporosis.  In:  Osteoporosis.  Eds.  Marcus, Feldman and Kelsey, Academic Press, San Diego CA 1996:1191-1208

135.   Dawson-Hughes B, Fowler SE, Dalsky G, Gallagher C.  Sodium excretion influences calcium homeostasis in elderly men and women.  Human & Clin Nutr.  1996:2107-2112

136.   Kinyamu HK, Gallagher JC, Petranick K, Ryschon KL.  Effect of parathyroid hormone (hPTH (1-34) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.  J Bone Min Res 1996; 11(10):1-11

137.   Gallagher JC.  The role of vitamin D in the pathogenesis and treatment of osteoporosis. J. Rheumatology  996; 23(45):15-18

138.   Kinyamu HK, Gallagher JC, Balhorn KE, Petranick KM, Rafferty KA.
Serum vitamin D metabolites and calcium absorption in normal young a
nd elderly free-living women and in women living in nursing homes
Am J Clin Nutr 1997;65:790-7

139.   Kinyamu HK, Gallagher JC, Knezetic JA, DeLuca HF, Prahl JM, Lanspa SJ. 
Effect of vitamin D receptor genotypes on calcium absorption, duodenal
vitamin D receptor concentration, and serum 1,25 dihydroxyvitamin D l
evels in normal women.  Calcif Tissue Int 1997; 60:491-495

140.   Krall E, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS, Dalsky G. 
Bone mineral density and biochemical markers of bone turnover in healthy
elderly men and women.  J Gerontology 1997; 52:M61-M67.

141.   Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ. 
Association between intestinal vitamin D receptor, calcium absorption,
and serum 1,25 dihydroxyvitamin D in normal young and elderly women. 
J Bone Miner Res  1997; 12:922-928.

142.   Gallagher JC.  Calcitriol and 1a hydroxy D3 are effective treatments for 
osteoporosis.  In:  Vitamin D.  Chemistry, Biology and Clinical Applications
of the Steroid Hormone.  Eds:  Norman, Bouillon, Thomasset.  10th
Workshop on Vitamin D.  Strasbourg, France. 1997:817-822

143.   Kinyamu HK, Gallagher JC, DeLuca HF, Prahl JM.  Age related changes
in calcium absorption, intestinal vitamin D receptor and serum 1,25
dihyroxyvitamin  In:  Vitamin D.  Chemistry, Biology and Clinical
Applications of the Steroid Hormone.  Eds:  Norman, Bouillon,
Thomasset.  10th Workshop on Vitamin D.  Strasbourg, France. 97:887-888

144.   Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG.  Bone density, bone turnover, and hormone levels in men over age 75    J-Gerontol-A-Biol-Sci-Med-Sci. 1998 Nov; 53(6): M419-25

145.   Gallagher JC.  Vitamin D treatment in osteoporosis and osteomalacia.  In:  Osteoporosis.  Eds. J. Stevenson and R. Lindsay  . Chapman & Hall.  London   1998:243-256

146.   Kinyamu HK, Gallagher JC, Rafferty KA, Balhorn KE.  Dietary calcium and vitamin   D intake in elderly women:  effect on serum parathyroid hormone and vitamin D  metabolites.  Am J Clin Nutr  1998;67:342-8.

147.   Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dalsky GP, Sherman.  Calciotropic hormones and bone markers in the elderly.  J Bone Min Res  1998; 13(3)475-482

148.   Utian WH, Burry KA, Archer DF, Gallagher JC, Boyett RL, Guy MP, Tachon GJ,  Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system compared with  placebo on vasomotor symptoms in highly symptomatic menopausal patients.  The Esclim study group.  Am J Obstet Gynecol.181:71-79,1999

149.   Gallagher JC.  Osteoporosis.  In:  Connís Current Therapy.  Eds: R.Rakel.  WB Saunders.  Philadelphia 1999

150.   Gallagher JC.  Moderation of the daily dose of HRT: prevention of osteoporosis  Maturitas 33,S57-63, 1999

151.   Schneider HPG, Gallagher JC.  Moderation of the daily dose of HRT: Benefits for patients. Maturitas 33(S1) 25-31,1999

152.   Utian W, Gallagher JC, Lindsay R, McLung MR, Nelson ME.  Postmenopausal Osteoporosis. Strategies for Prevention and Treatment Monograph 1999

153.   Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL.  Smoking and Bone Metabolism in Elderly women. Bone 27:429-436,2000 Sep

154.   Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL.  Alcohol Intake and Bone metabolism in Elderly Women. Am J Clin Nutr.72: 1206-1213,2000 Nov

155.   Nuti R,  Bonucci E, Brancaccio D, Gallagher JC, Gennari C, Mazzuoli G, Passeri M, Sambrook P.  The role of calcitriol in the treatment of osteoporosis.  Calcif Tissue Int.  2000.Mar;66(3):239-40.

156.   Utian W, Gass M, Sullivan J, Stettin GD Gallagher JC.  A decision tree for the use of replacement therapy or Hormone replacement therapy in Postmenopausal women.  Consensus Opinion of the North American Menopause Society  Menopause 7,2,76-86,2000

157.   Santoro N.  Altman A, Archer D, Gallagher JC.  The promise of HRT. Contemporary  Ob.Gyn June 4-25, 2000

158.   Consensus Opinion.  The Role of Calcium in Peri- and postmenopausal women.  Menopause.8, (2), 84-95, 2001.

159.   Gallagher JC.  The role of Estrogen in the prevention of Osteoporosis in Rheumatic Disease Clinics of North America .27,(1),84-95,2001

160.   Speroff L ,Gallagher JC, Pinkerton J, Raisz L ,Montgomery Rice V.  The Impact of low dose HRT Contemporary ObGyn.2001

161.   Gallagher JC, Fowler S, Sherman SS.  Combination treatment with Estrogen and Calcitriol in the prevention of  Age-Related Bone Loss.  J.Clin.Endocrinol.Metab 86:3618- 3628, 2001.

162.   Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL.  Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001 Nov;74(5):694-700.

163.   Gallagher JC, Baylink DJ, Freeman R, McClung M.  Prevention of Bone Loss with Tibolone in Postmenopausal Women: Results of Two Randomized, Double blind, Placebo controlled, Dose-Finding Studies.  J. Clin Endocrinol Metab. 86(10): 4717-4726, 2001 Oct

164.   Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V.  Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women.  J Clin Endocrinol Metab. 2002 May;87(5):2024-32.

165.   Lindsay R, Gallagher JC, Kleerekopper M, Pickar JH.  Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.  JAMA. 2002 May 22-29; 287(20):2668-76

166.   Gallagher JC Rapuri PB, Haynatzka G, Detter JR.  Effect of Discontinuation of Estrogen, Calcitriol and the Combination of both on Bone Density and Bone Markers.  J Clin Endocrinol Metab 2002 (Nov) 87:4914-4923,2002

167.   Gallagher JC.  Tibolone is effective in preventing postmenopausal bone loss.  In Womenís Health and Menopause. Ed.  Lobo RA, Crosignani PG, Paoletti R, Bruschi F. Kluwer-Boston 2002


168.   Rapuri PB, Gallagher JC, Haynatzka V.  Protein Intake- Effect on Bone Mineral  Density and the Rate of Bone Loss in elderly Women Am J Clin Nutr 77:1517-1525 2003

169.   Gallagher JC, Rapuri PB.  Osteoporosis: Pathophysiology.  in Encyclopedia of Hormones. Academic Press New York 2003

170.   Rapuri, PB, Gallagher, JC, Haynatski G.  Effect of Vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter.  Calcif Tissue Int 74:150-156, 2004.

171.   Rapuri PB, Gallagher JC.  Effect of Vitamin D supplement use on serum concentrations of total 25OHD levels in elderly women.  J Steroid Biochem Mol Biol.  May; 89-90(1-5):601-4,2004.

172.   Gallagher JC, Satpathy R, Rafferty K, Haynatzka V.  The Effect of Soy Protein Isolate on Bone Metabolism. Menopause 2004 11(3), 290-298

173.   Rapuri PB, Gallagher JC, Knezetic JA, Kinyamu HK, Ryschon KL.  Association between Vitamin D receptor polymorphisms and the rate of bone loss in elderly women-importance of adjusting for dietary and lifestyle factors.  JSteroid Biochem Mol Biol.  2004 May; 89-90(1-5):503-6.

174.   Gallagher JC.  The effects of calcitriol on falls and fractures and physical performance tests.  J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):497-501

175.   Rapuri PB, Gallagher JC, Haynatzki G.  Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women.  J Clin Endocrinol Metab.  Oct; 89(10):4954-62,2004.

176.   Gallagher JC.  Remedies for Vitamin D deficiency.  Comment. J  Musculoskeletal Medicine.21(12):  617,2004

177.   Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH.  Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures.  J Clin Endocrinol Metab. 2004 Dec 21

178.   Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC, Pavo I, Wang J, Eriksen EF.  Early Changes In Biochemical Markers Of Bone Formation Correlate with Improvements In Bone Structure During Teriparatide Therapy.  J Clin Endocrinol Metab. 2005; July 90(7):3970-7

179.   Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.  Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.  Osteoporos Int. 2005 Apr;16(4):372-9.

180.   Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.  Related Articles. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.  Maturitas. 2006; 20;53(4):371-9.

181.   Gong G, Haynatski G,Haynatska, V,Kosoko-Lasaki S, Howell R, Fu Yun Xin, Gallagher JC, Wilson R.  Bone Mineral Density of Recent African Immigrants in the United States.  J Nat Int Med Assoc, 2006 .98:5;746-752.

182.   Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF.  Related Articles, Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.  J Bone Miner Res. 2006 Jun;21(6):855-64.

183.   Gallagher JC, Rosen CJ, Chen P, Misurski DA, Marcus R.  Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.  Bone. 39(6):1268-75,2006

184.   Gong G, Haynatzki G, Haynatzka V, Howell R, Kosoko-Lasaki S, Fu YX, Yu F, Gallagher JC, Wilson MR.  Bone mineral density-affecting genes in Africans.  J Natl Med Assoc. (7):1102-8,2006

185.   Gallagher JC, Rapuri PB, Smith LM.  An Age Related Decrease in Creatinine Clearance is Associated with an Increase in Number of Falls in Untreated Women but not in Women Receiving Calcitriol Treatment.  J Clin Endocrinol Metab. 2007 Jan 92:51-58, 2007

186.   Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.  Related Articles. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.  Maturitas. 2006; 20;53(4)

187.   Archer DF, Hendrix S, Gallagher JC, Rymer J, Skouby S, Ferenczy A, den Hollander W, Stathopoulos V, Helmond FA.  Endometrial Effects of  Tibolone.  J Clin Endocrinol Metab. 2007 Mar;92(3):911-8.

188.   Rapuri PB, Gallagher JC, Nawaz Z.Caffeine decreases vitamin D receptor protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase activity in human osteoblast cells.  J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):368-71.

189.   Gallagher JC, Rapuri P, Smith L.  Falls are associated with decreased renal function and insufficient calcitriol production by the kidney.J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):610-3.

190.   Rapuri PB, Gallagher JC, Smith LM.  Smoking is a risk factor for decreased physical performance in elderly women. J Gerontol A Biol Sci Med Sci. 2007 Jan;62(1):93-100.

191.   Gallagher JC.  Effect of early menopause on bone mineral density and fractures.  Menopause.  2007 May-Jun;14(3

192.   Benchimol EI, Ward LM, Gallagher JC, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease .J Pediatr Gastroenterol Nutr. 2007 Nov;45(5):538-45.

193.   Archer DF, Hendrix S, Ferenczy A, Felix J, Gallagher JC, Rymer J, Skouby SO, den Hollander W, Stathopoulos V, Helmond FA; THEBES Study Group. Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.            Fertil Steril. 2007 Oct;88(4):866-78.

194.   Gallagher JC. Advances in bone biology and new treatments for bone loss. Maturitas. 2008 60 (1):65-9  

195.   Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, Henderson VW, Hodis HN,      Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA.Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Menopause. 2008 Jul-Aug; 15(4 Pt 1):584-602.

196.   Gallagher JC.Does tibolone reduce the risk of fracture in older postmenopausal women with osteoporosis? Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):128-9.

197.   Vupadhyayula PM, Gallagher JC, Templin T, Logsdon SM, Smith LM. Effects of soy protein isolate on bone mineral density and physical performance indices in postmenopausal women--a 2-year randomized, double-blind, placebo-controlled trial.Menopause. 2009 Mar-Apr;16(2):320-8.

198.   Gallagher JC, Sai AJ. Bone: Is screening for secondary causes of osteoporosis worthwhile? Nat Rev Endocrinol. 2010 Jul;6(7):360-2.

199.   Henry HL, Bouillon R, Norman AW, Gallagher JC, Lips P, Heaney RP, Vieth R, Pettifor JM, Dawson-Hughes B, Lamberg-Allardt CJ, Ebeling PR. 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):4-6.

200.   Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010 Jun;95(6):2630-3.

201.   Sai AJ, Gallagher JC, Smith LM, Logsdon S Fall predictors in the community dwelling elderly: a cross sectional and prospective cohort study. J Musculoskelet Neuronal Interact. 2010 Jun;10(2):142-50.

202.   Gallagher JC, Sai AJ. Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas. 2010 Apr;65(4):301-7.

203.   Gallagher JC, Sai AJ. Bisphosphonate use in osteoporosis: cardiovascular effects. Menopause. 2010 Jan-Feb;17(1):5-7.

204.   Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G. Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril. 2009 Sep;92(3):1045-5.

 Click hear to see a current listing of publications